F.D.A. issues emergency authorization for convalescent plasma as Covid-19 treatment

The US Food and Drug Administration has approved the use of convalescent plasma as Covid-19 treatment as the "known and potential benefits of the product outweigh the known and potential risks of the product." Even before the approval, around 70,000 people had been treated with convalescent plasma.

President Trump, after harshly criticising the speed of approval of treatments and vaccines, was pleased with the fast decision. "Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives. Today's action will dramatically increase access to this treatment," so the President.